Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
10.01
+0.10 (1.01%)
At close: Aug 13, 2025, 4:00 PM
10.10
+0.09 (0.90%)
After-hours: Aug 13, 2025, 4:40 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $871.32 million as of August 13, 2025. Its market cap has decreased by -12.00% in one year.
Market Cap
871.32M
Enterprise Value
623.97M
1-Year Change
-12.00%
Ranking
Category
Stock Price
$10.01
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $871.32M, an increase of 682.22%. That is a compound annual growth rate of 52.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 862.62M | 30.13% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |